Julie H. McHugh
Net Worth
Last updated:
What is Julie H. McHugh net worth?
The estimated net worth of Ms. Julie H. McHugh is at least $1,617,116 as of 10 Jun 2024. She owns shares worth $153,341 as insider, has earned $703,775 from insider trading and has received compensation worth at least $760,000 in Ironwood Pharmaceuticals, Inc..
What is the salary of Julie H. McHugh?
Ms. Julie H. McHugh salary is $95,000 per year as Executive Chairman in Ironwood Pharmaceuticals, Inc..
How old is Julie H. McHugh?
Ms. Julie H. McHugh is 61 years old, born in 1964.
What stocks does Julie H. McHugh currently own?
As insider, Ms. Julie H. McHugh owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | Executive Chairman | 139,528 | $1.1 | $153,341 |
What does Ironwood Pharmaceuticals, Inc. do?
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Julie H. McHugh insider trading
Ironwood Pharmaceuticals, Inc.
Ms. Julie H. McHugh has made 12 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently she sold 22,766 units of IRWD stock worth $143,198 on 10 Jun 2024.
The largest trade she's ever made was exercising 22,766 units of IRWD stock on 10 Jun 2024. As of 10 Jun 2024 she still owns at least 139,528 units of IRWD stock.
Ironwood Pharmaceuticals key executives
Ironwood Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Michael Shetzline M.D., Ph.D. (66) Chief Medical Officer, Senior Vice President and Head of R&D
- Mr. Jason Rickard (54) Chief Operating Officer & Senior Vice President of Operations
- Mr. Thomas A. McCourt (68) Chief Executive Officer & Director
- Ms. Julie H. McHugh (61) Executive Chairman